AKT1 and cancer: IRS2 is an insulin-like growth factor-1 receptor (IGF-1R) and insulin receptor signaling transmitter, which may be involved in the PI3K-AKT pathway, leading to the occurrence and progression of malignant tumors and inhibition of apoptosis (45, 46).